Use of 5-fluorocytosine in patients with impaired renal function
- PMID: 4749757
- PMCID: PMC1587832
- DOI: 10.1136/bmj.4.5889.382
Use of 5-fluorocytosine in patients with impaired renal function
Abstract
The plasma level and elimination of 5-fluorocytosine (5-FC) was measured in normal subjects and patients with impaired renal function. Prolongation of the half-life of the drug in renal failure has been confirmed. Renal clearance of 5-FC was about 75% of the creatinine clearance and a corresponding modification of drug dosage should be made in patients with renal insufficiency.
Similar articles
-
Clinical pharmacokinetics of systemic antifungal drugs.Clin Pharmacokinet. 1983 Jan-Feb;8(1):17-42. doi: 10.2165/00003088-198308010-00002. Clin Pharmacokinet. 1983. PMID: 6301738 Review. No abstract available.
-
Pharmacokinetic studies on the oral antimycotic agent 5-fluorocytosine in individuals with normal and impaired kidney function.Chemotherapy. 1973;18(6):321-36. doi: 10.1159/000221279. Chemotherapy. 1973. PMID: 4741211 No abstract available.
-
Flucytosine kinetics in subjects with normal and impaired renal function.Clin Pharmacol Ther. 1978 Sep;24(3):333-42. doi: 10.1002/cpt1978243333. Clin Pharmacol Ther. 1978. PMID: 688726 No abstract available.
-
5-Fluorocytosine kinetics in patients with acute renal failure undergoing continuous hemofiltration.Chemotherapy. 1987;33(2):77-84. doi: 10.1159/000238478. Chemotherapy. 1987. PMID: 3568800
-
The longest use of liposomal amphotericin B and 5-fluorocytosine in neonatal renal candidiasis.Pediatr Nephrol. 2004 Jul;19(7):801-4. doi: 10.1007/s00467-004-1463-7. Epub 2004 May 15. Pediatr Nephrol. 2004. PMID: 15173938 Review.
Cited by
-
Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.J Pharmacokinet Biopharm. 1975 Oct;3(5):333-83. doi: 10.1007/BF01082306. J Pharmacokinet Biopharm. 1975. PMID: 1107513 Review. No abstract available.
-
Clinical pharmacokinetics of systemic antifungal drugs.Clin Pharmacokinet. 1983 Jan-Feb;8(1):17-42. doi: 10.2165/00003088-198308010-00002. Clin Pharmacokinet. 1983. PMID: 6301738 Review. No abstract available.
-
Drug kinetics and artificial kidneys.Clin Pharmacokinet. 1977 Nov-Dec;2(6):403-26. doi: 10.2165/00003088-197702060-00002. Clin Pharmacokinet. 1977. PMID: 22417
-
Peritoneal clearance of amphotericin B and 5-fluorocytosine.West J Med. 1980 Aug;133(2):157-60. West J Med. 1980. PMID: 7015695 Free PMC article. No abstract available.
-
Pharmacokinetics of amphotericin B and flucytosine.Postgrad Med J. 1979 Sep;55(647):667-70. doi: 10.1136/pgmj.55.647.667. Postgrad Med J. 1979. PMID: 523358 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources